BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 34502487)

  • 1. Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
    Karaźniewicz-Łada M; Główka AK; Mikulska AA; Główka FK
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed.
    Yalcin N; Allegaert K
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1697-1701. PubMed ID: 35930055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
    Devinsky O; Patel AD; Thiele EA; Wong MH; Appleton R; Harden CL; Greenwood S; Morrison G; Sommerville K;
    Neurology; 2018 Apr; 90(14):e1204-e1211. PubMed ID: 29540584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
    Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
    Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiepileptic drugs: review on drug interactions.
    Hachad H; Ragueneau-Majlessi I; Levy RH
    Ther Drug Monit; 2002 Feb; 24(1):91-103. PubMed ID: 11805729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.
    VanLandingham KE; Crockett J; Taylor L; Morrison G
    J Clin Pharmacol; 2020 Oct; 60(10):1304-1313. PubMed ID: 32652616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL; Absalom NL; Abelev SV; Low IK; Doohan PT; Martin LJ; Chebib M; McGregor IS; Arnold JC
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.
    Patsalos PN; Perucca E
    Lancet Neurol; 2003 Jun; 2(6):347-56. PubMed ID: 12849151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between cannabidiol and commonly used antiepileptic drugs.
    Gaston TE; Bebin EM; Cutter GR; Liu Y; Szaflarski JP;
    Epilepsia; 2017 Sep; 58(9):1586-1592. PubMed ID: 28782097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS; Hoppu K; Nergårdh A; Boreus L
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
    Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
    Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.
    Patsalos PN; Spencer EP; Berry DJ
    Ther Drug Monit; 2018 Oct; 40(5):526-548. PubMed ID: 29957667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiepileptic drugs that are second generation to existing antiepileptic drugs.
    Bialer M
    Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.